CDIOCARDIO DIAGNOSTICS HOLDINGS, INC.
8-K3.019.01

Jun 7, 2024

Get CDIO alerts

CDIO 8-K — Smart Summary

68% reduction

On June 3, 2024, Cardio Diagnostics Holdings, Inc. received a written notice from Nasdaq indicating non-compliance with Nasdaq Listing Rule 5550(a)(2) due to the Company's common stock minimum bid price falling below $1.00 per share for 30 consecutive business days. The Notice has no immediate effect on the listing or trading of the Company's common stock or warrants on the Nasdaq Capital Market.

Details

  • On June 3, 2024, the Company received a written notice from The Nasdaq Stock Market LLC regarding non-compliance with Nasdaq Listing Rule 5550(a)(2)
  • Non-compliance reason: minimum bid price of the Company's common stock has been below $1.00 per share for 30 consecutive business days
  • The Notice has no immediate effect on the listing or trading of the Company's common stock or warrants on the Nasdaq Capital Market
  • The Company has 180 calendar days, until December 2, 2024 (the 'Compliance Date'), to regain compliance with the minimum bid price requirement
  • Compliance can be regained if the bid price for the Common Stock closes at $1.00 per share or more for a minimum of ten consecutive business days before the Compliance Date
  • If the Company does not regain compliance by December 2, 2024, it may be eligible for an additional 180 calendar day compliance period
  • To qualify for the additional period, the Company must meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for Nasdaq Capital Market, except the minimum bid price requirement, and provide written notice to Nasdaq of its intention to cure the deficiency
  • If the Company fails to regain compliance during the compliance period (including a second compliance period, if applicable), Nasdaq will notify the Company of its determination to delist its common stock
  • The Company may appeal any Nasdaq delisting determination to a Nasdaq hearing panel
  • The Company intends to actively monitor the closing bid price of its common stock and will consider all available options to regain compliance, which may include effecting a reverse stock split
  • The Company's common stock trades under the symbol CDIO and its Redeemable Warrants trade under the symbol CDIOW, both on The Nasdaq Stock Market LLC
  • Common Stock par value is $0.00001; each Redeemable Warrant is exercisable for one share of Common Stock
§ MORE SUMMARIES

More CDIO Smart Summaries

Other filings for Cardio Diagnostics Holdings, Inc. with a Smart Summary.

8-K$CDIOSmart Summary
8-K Filing
AI-powered cardiac diagnostic tests target $176B U.S. market
Read summary of 8-K for CDIO
8-K$CDIOSmart Summary
8-K Filing
Stockholders approve three proposals at annual meeting with 52.6% voting
Read summary of 8-K for CDIO
8-K$CDIOSmart Summary
8-K Filing
Stock regains Nasdaq compliance after reaching $1.00 minimum bid price
Read summary of 8-K for CDIO
8-K$CDIOSmart Summary
8-K Filing
1-for-30 reverse stock split effective immediately
Read summary of 8-K for CDIO
8-K$CDIOSmart Summary
8-K Filing
Investor presentation highlights $300B cardiovascular market opportunity
Read summary of 8-K for CDIO
8-K$CDIOSmart Summary
8-K Filing
Nasdaq grants second 180-day extension to regain minimum bid price compliance
Read summary of 8-K for CDIO
8-K$CDIOSmart Summary
8-K Filing
Stockholders approve director slate, reverse split, and auditor ratification
Read summary of 8-K for CDIO
8-K$CDIOSmart Summary
8-K Filing
AI-driven cardiovascular tests target $300B market amid commercial expansion
Read summary of 8-K for CDIO

Never miss a CDIO filing

Get real-time email alerts when CDIO files with the SEC.

See plans